These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17502397)

  • 1. PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004.
    de Filippis I; de Andrade CF; Silva L; Prevots DR; Vicente AC
    Infect Immun; 2007 Jul; 75(7):3683-5. PubMed ID: 17502397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
    Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
    J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine.
    Sorhouet Pereira C; Regueira M; Mollerach M
    J Med Microbiol; 2008 Mar; 57(Pt 3):338-342. PubMed ID: 18287297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic.
    Dyet KH; Martin DR
    J Clin Microbiol; 2005 Feb; 43(2):838-42. PubMed ID: 15695689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of PorA during a meningococcal disease epidemic.
    Devoy AF; Dyet KH; Martin DR
    J Clin Microbiol; 2005 Feb; 43(2):832-7. PubMed ID: 15695688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?
    Clarke SC; Diggle MA; Mölling P; Unemo M; Olcén P
    Vaccine; 2003 Jun; 21(19-20):2468-73. PubMed ID: 12744880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.
    Sacchi CT; Lemos AP; Popovic T; De Morais JC; Whitney AM; Melles CE; Brondi LM; Monteiro LM; Paiva MV; Solari CA; Mayer LW
    J Clin Microbiol; 2001 Aug; 39(8):2897-903. PubMed ID: 11474010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.
    Zhou J; Lefebvre B; Deng S; Gilca R; Deceuninck G; Law DK; De Wals P; Tsang RS
    J Clin Microbiol; 2012 May; 50(5):1545-51. PubMed ID: 22337990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of meningococcal disease caused by PorA-deficient meningococci.
    van der Ende A; Hopman CT; Keijzers WC; Spanjaard L; Lodder EB; van Keulen PH; Dankert J
    J Infect Dis; 2003 Mar; 187(5):869-71. PubMed ID: 12599063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine.
    Climent Y; Urwin R; Yero D; Martinez I; Martín A; Sotolongo F; Maiden MC; Pajón R
    Infect Genet Evol; 2010 May; 10(4):546-54. PubMed ID: 20156598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of serogroup C Neisseria meningitidis isolated in China.
    Zhang X; Shao Z; Yang E; Xu L; Xu X; Li M; Ren J; Zhu Y; Yang F; Liang X; Mayer LW; Xu J; Jin Q
    J Med Microbiol; 2007 Sep; 56(Pt 9):1224-1229. PubMed ID: 17761487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.
    Martin DR; Ruijne N; McCallum L; O'Hallahan J; Oster P
    Clin Vaccine Immunol; 2006 Apr; 13(4):486-91. PubMed ID: 16603616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.
    Lucidarme J; Comanducci M; Findlow J; Gray SJ; Kaczmarski EB; Guiver M; Vallely PJ; Oster P; Pizza M; Bambini S; Muzzi A; Borrow R
    Clin Vaccine Immunol; 2010 Jun; 17(6):919-29. PubMed ID: 20375242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic characterization of Neisseria meningitidis serogroup B strains circulating in China.
    Yang L; Shao Z; Zhang X; Xu L; Peng J; Xu X; Liang X; Qi Y; Jin Q
    J Infect; 2008 Mar; 56(3):211-8. PubMed ID: 18215423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada.
    Tsang RS; Tsai CM; Zhu P; Ringuette L; Lorange M; Law DK
    J Clin Microbiol; 2004 Apr; 42(4):1460-5. PubMed ID: 15070989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998.
    Sacchi CT; Whitney AM; Popovic T; Beall DS; Reeves MW; Plikaytis BD; Rosenstein NE; Perkins BA; Tondella ML; Mayer LW
    J Infect Dis; 2000 Oct; 182(4):1169-76. PubMed ID: 10979914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.
    Tsang RS; Hoang L; Tyrrell G; Horsman G; Wylie J; Jamieson FB; Lefebvre B; Taha MK
    J Med Microbiol; 2015 Feb; 64(Pt 2):174-9. PubMed ID: 25627205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in serogroup C meningococcal disease in Canada is associated with antigenic changes in the protein antigens of the ET-15 clone of Neisseria meningitidis.
    Tsang RS; Law DK; Henderson AM; Blake ML; Stoltz J
    J Infect Dis; 2006 Dec; 194(12):1791-2; author reply 1792-3. PubMed ID: 17109354
    [No Abstract]   [Full Text] [Related]  

  • 19. Invasive culture-confirmed Neisseria meningitidis in Portugal: evaluation of serogroups in relation to different variables and antimicrobial susceptibility (2000-2001).
    Caniça M; Dias R; Nunes B; Carvalho L; Ferreira E; The Meningococci Study Group
    J Med Microbiol; 2004 Sep; 53(Pt 9):921-925. PubMed ID: 15314201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain.
    Alcalá B; Salcedo C; Arreaza L; Abad R; Enríquez R; De La Fuente L; Uría MJ; Vázquez JA
    J Med Microbiol; 2004 Jun; 53(Pt 6):515-518. PubMed ID: 15150331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.